| Proposed Maximum Aggregate Value of Transaction | Fee Rate | Amount of Filing Fee | ||
| | (1) | $ | | $ |
| Fees Previously Paid | — | — | ||
| Total Transaction Valuation | $ | |||
| Total Fees Due for Filing | $ | |||
| Total Fees Previously Paid | $ | |||
| Total Fee Offsets | $ | |||
| Net Fee Due | $ |
| (1) | Capitalized terms used below but not defined herein shall have the meanings assigned to such terms in the Agreement and Plan of Merger, dated as of July 14, 2026 (the “Merger Agreement”), by and among Senti Biosciences Holdings, Inc. (the “Company”), Senti Holdings, Inc., Senti Biosciences, Inc., Celadon Partners SPV 35 Limited and Senti Merger Sub, Inc. In accordance with Rule 0-11 under the Securities Exchange Act of 1934, the filing fee has been calculated on the basis of the maximum aggregate consideration payable pursuant to the Merger Agreement, which is $60,000,000.00, representing the aggregate cap on all Milestone Payment Amounts. The filing fee equals $8,286, calculated at a rate of $138.10 per $1,000,000 of transaction value. |